T4 retroperitoneal liposarcoma. Challenges of big size sarcomas surgical treatment

Our article presents some of the challenges of the surgical treatment of T4 (>15 cm) retroperitoneal liposarcomas (up to 65∕56∕30 cm, 25.5 kg) series of cases treated by the Department of Surgical Oncology, Prof. Dr. Ion Chiricuţă Oncology Institute, Cluj-Napoca (IOCN), Romania, with illustration...

Full description

Saved in:
Bibliographic Details
Published inRomanian journal of morphology and embryology Vol. 62; no. 1; pp. 125 - 132
Main Authors Nistor-Ciurba, Codruţ Cosmin, Lisencu, Ioan Cosmin, Tat, Tiberiu Florin, Andrieş, Alexandra Ioana, Fetică, Bogdan, Căinap, Călin Ioan, Eniu, Dan Tudor
Format Journal Article
LanguageEnglish
Published Romania Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Our article presents some of the challenges of the surgical treatment of T4 (>15 cm) retroperitoneal liposarcomas (up to 65∕56∕30 cm, 25.5 kg) series of cases treated by the Department of Surgical Oncology, Prof. Dr. Ion Chiricuţă Oncology Institute, Cluj-Napoca (IOCN), Romania, with illustrations, insisting on important blood vessels and nerves dissection and preservation and discussions of strategies with references to important articles from the last 10 years specialty literature. Challenges do not come only from intraoperative difficulties but also from establishing the right attitude from the extent of resection and oncological safety point of view, the role of the pathologist being very important because histological subtype and completeness of the resections are the most important prognostic factors for such tumors. Despite all today available aids in decision making, like nomograms or high-resolution imagery, sometimes this decision is to be taken intraoperative based on surgeon's expertise and skills. That is why is strongly advised that such cases to be treated in high-volume specialized tertiary centers of surgical oncology.
ISSN:1220-0522
2066-8279
DOI:10.47162/RJME.62.1.12